DCNSF(DCNSF)
DCNSF
No analyst ratings available
No analyst price targets available for DCNSF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $10.86T | $11.03T | $11.25T | $11.64T | $11.99T |
| Low | $10.50T | $9.90T | $10.48T | $10.85T | $11.17T |
| High | $11.14T | $11.90T | $11.84T | $12.25T | $12.62T |
| EBITDA Avg | $732.55B | $744.50B | $758.90B | $785.56B | $808.93B |
| Low | $708.09B | $667.63B | $707.13B | $731.98B | $753.75B |
| High | $751.94B | $803.07B | $798.72B | $826.79B | $851.38B |
| EBIT Avg | $598.55B | $608.31B | $620.07B | $641.86B | $660.95B |
| Low | $578.56B | $545.50B | $577.78B | $598.08B | $615.87B |
| High | $614.39B | $656.17B | $652.62B | $675.55B | $695.64B |
| Net Income Avg | $3.28B | $3.44B | $3.57B | $3.62B | $3.75B |
| Low | $2.99B | $3.14B | $3.26B | $3.30B | $3.42B |
| High | $3.50B | $3.68B | $3.82B | $3.87B | $4.01B |
| EPS Avg | $142.88 | $149.95 | $155.72 | $157.75 | $163.50 |
| Low | $130.21 | $136.66 | $141.92 | $143.76 | $149.01 |
| High | $152.63 | $160.18 | $166.35 | $168.51 | $174.66 |
| Analysts (Rev / EPS) | 4 / 1 | 5 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $2.59T | $2.89T | $2.82T | $2.75T | $2.80T | $2.86T | $2.92T | $2.98T |
| Low | $2.59T | $2.89T | $2.82T | $2.75T | $2.80T | $2.86T | $2.92T | $2.98T |
| High | $2.59T | $2.89T | $2.82T | $2.75T | $2.80T | $2.86T | $2.92T | $2.98T |
| EBITDA Avg | $175.03B | $195.23B | $190.38B | $185.31B | $189.13B | $193.02B | $197.00B | $201.05B |
| Low | $175.03B | $195.23B | $190.38B | $185.31B | $189.13B | $193.02B | $197.00B | $201.05B |
| High | $175.03B | $195.23B | $190.38B | $185.31B | $189.13B | $193.02B | $197.00B | $201.05B |
| EBIT Avg | $143.01B | $159.52B | $155.55B | $151.41B | $154.53B | $157.71B | $160.96B | $164.28B |
| Low | $143.01B | $159.52B | $155.55B | $151.41B | $154.53B | $157.71B | $160.96B | $164.28B |
| High | $143.01B | $159.52B | $155.55B | $151.41B | $154.53B | $157.71B | $160.96B | $164.28B |
| Net Income Avg | $122.69B | $152.54B | $143.71B | $120.96B | $144.88B | $175.49B | $167.41B | $129.89B |
| Low | $122.69B | $152.54B | $143.71B | $120.96B | $144.88B | $175.49B | $167.41B | $129.89B |
| High | $122.69B | $152.54B | $143.71B | $120.96B | $144.88B | $175.49B | $167.41B | $129.89B |
| EPS Avg | $34.07 | $42.36 | $39.91 | $33.59 | $40.23 | $48.74 | $46.49 | $36.07 |
| Low | $34.07 | $42.36 | $39.91 | $33.59 | $40.23 | $48.74 | $46.49 | $36.07 |
| High | $34.07 | $42.36 | $39.91 | $33.59 | $40.23 | $48.74 | $46.49 | $36.07 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |